Heather Robison, MPP

Sr Director, Biostatistics
BioXcel Therapeutics

TBD

Poster(s):

• (122) Sublingual Dexmedetomidine for the Treatment of Acute Agitation Associated with Schizophrenia or Bipolar Disorder: Effect Size and Pooled Efficacy